SCHEMBL5338915

SCHEMBL5338915

CCCc1ccc(S(=O)(=O)Nc2ccc3oncc3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
ATM Q13315 2/20 0.53
KIT P10721 2/20 0.49
FFAR4 Q5NUL3 2/20 0.48
NR1I2 O75469 1/20 0.47
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN5 P54829 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
FFAR1 O14842 1/20 0.46
DRD2 P14416 6/20 0.46
DRD3 P35462 6/20 0.46
HTR6 P50406 5/20 0.46
POLB P06746 1/20 0.46
HTR2A P28223 4/20 0.45
HTR2C P28335 4/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5383091 0.78 MAPT (0.55) MAPTATMKITFFAR4NR1I2
SCHEMBL616006 0.78 PTPN2 (0.59) MAPTATMKITFFAR4NR1I2
SCHEMBL31681385 0.76 MEN1 (0.55) MAPTATMKITFFAR4NR1I2
SCHEMBL9343342 0.76 CNR1 (0.39) KMT2APOLB
SCHEMBL617843 0.75 MAPT (0.55) MAPTATMKITFFAR4NR1I2
SCHEMBL5344513 0.75 ATM (0.52) MAPTATMKITFFAR4NR1I2
SCHEMBL5335572 0.75 MAPT (0.57) MAPTATMKITFFAR4NR1I2
SCHEMBL5335098 0.74 CDC7 (0.68) MAPTATMKITFFAR4NR1I2
SCHEMBL5340962 0.74 ALDH1A1 (0.72) MAPTATMKITFFAR4NR1I2
SCHEMBL5337489 0.73 ATM (0.55) MAPTATMKITFFAR4NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 MAPT 4512/4885ATM 4236/4885KIT 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.